TickerLeague

Buyback Spend for Incyte (INCY)

Buyback Spend for Incyte (INCY): headline value $19.10M · YoY -99.0%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Incyte Corporation logo
Incyte

INCY

Latest period

$19.10M

YoY change

-99.0%

5Y CAGR

N/A

Peak year (2024)

$2.00B

Latest annual

$19.10M

Buyback Spend history chart for Incyte (INCY) from 1993 to 2025

Buyback Spend history table for Incyte (INCY) from 1993 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$19.10M-99.0%
2024$2.00B
2023$0
2022$0
2021$0
2020$0
2019$0
2018$0
2017$0
2016$0
2015$0
2014$0
2013$0
2012$0
2011$0
2010$0
2009$0
2008$0
2007$0
2006$0
2005$0
2004$0-100.0%
2003$105,000-98.2%
2002$5.72M
2001$0
2000$0
1999$0
1998$0
1997$0
1996$0
1995$0
1994$0
1993$0

Buyback Spend values are taken from Incyte's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Incyte (INCY) most recent annual buyback spend stands at $19.10M (2025) – plunged 99.0% year-over-year.

Between 2024 and 2025, Incyte buyback spend plunged 99.0%, falling from $2.00B to $19.10M.

The highest annual buyback spend of $2.00B was reported in 2024. The lowest in the available history was $0 in 1993.

Among 8 Healthcare peers, Incyte (INCY) ranks 8th; the peer median for buyback spend is $2.75B.

Incyte Buyback Spend by Year

Incyte Buyback Spend 2025: $19.10M

Incyte buyback spend in 2025 was $19.10M, plunged 99.0% below 2024.

Incyte Buyback Spend 2024: $2.00B

Incyte buyback spend in 2024 was $2.00B.

Incyte Buyback Spend 2023: $0

Incyte buyback spend in 2023 was $0.

Incyte Buyback Spend 2022: $0

Incyte buyback spend in 2022 was $0.

Incyte Buyback Spend 2021: $0

Incyte buyback spend in 2021 was $0.

See more financial history for Incyte (INCY).

Sector peers — Buyback Spend

Companies in the same sector as Incyte, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Incyte's buyback spend?

Latest reported buyback spend for Incyte (INCY) is $19.10M (period ending March 31, 2026).

How has Incyte buyback spend changed year-over-year?

Incyte (INCY) buyback spend changed -99.0% year-over-year on the latest annual filing.

When did Incyte buyback spend hit its highest annual value?

Incyte buyback spend reached its highest annual value of $2.00B in 2024.

What was Incyte buyback spend in 2024?

Incyte (INCY) buyback spend in 2024 was $2.00B.

What was Incyte buyback spend in 2025?

Incyte (INCY) buyback spend in 2025 was $19.10M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.